633 related articles for article (PubMed ID: 21436238)
21. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap.
Clark KJ; Griffiths J; Bailey KM; Harcum SW
Biotechnol Bioeng; 2005 Jun; 90(5):568-77. PubMed ID: 15818560
[TBL] [Abstract][Full Text] [Related]
22. Effect of mild-thiol reducing agents and alpha2,3-sialyltransferase expression on secretion and sialylation of recombinant EPO in CHO cells.
Chang KH; Jeong YT; Kwak CY; Choi O; Kim JH
J Microbiol Biotechnol; 2013 May; 23(5):699-706. PubMed ID: 23648861
[TBL] [Abstract][Full Text] [Related]
23. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
24. [Extracellular sialidase degrades sialic acid in recombinant human erythropoietin produced by an industrial Chinese hamster ovary cell strain].
Liu Y; Zhou X; Liu H; Song Z; Zhang Y
Sheng Wu Gong Cheng Xue Bao; 2012 Dec; 28(12):1492-9. PubMed ID: 23593873
[TBL] [Abstract][Full Text] [Related]
25. Amino acid residues important for CMP-sialic acid recognition by the CMP-sialic acid transporter: analysis of the substrate specificity of UDP-galactose/CMP-sialic acid transporter chimeras.
Takeshima-Futagami T; Sakaguchi M; Uehara E; Aoki K; Ishida N; Sanai Y; Sugahara Y; Kawakita M
Glycobiology; 2012 Dec; 22(12):1731-40. PubMed ID: 22833315
[TBL] [Abstract][Full Text] [Related]
26. Enhancing the sialylation of recombinant EPO produced in CHO cells via the inhibition of glycosphingolipid biosynthesis.
Kwak CY; Park SY; Lee CG; Okino N; Ito M; Kim JH
Sci Rep; 2017 Oct; 7(1):13059. PubMed ID: 29026192
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the coordinated role of ST3GAL3, ST3GAL4 and ST3GAL6 on the α2,3 sialylation linkage of mammalian glycoproteins.
Chung CY; Yin B; Wang Q; Chuang KY; Chu JH; Betenbaugh MJ
Biochem Biophys Res Commun; 2015 Jul; 463(3):211-5. PubMed ID: 25998389
[TBL] [Abstract][Full Text] [Related]
28. Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases.
Fukuta K; Yokomatsu T; Abe R; Asanagi M; Makino T
Glycoconj J; 2000 Dec; 17(12):895-904. PubMed ID: 11511814
[TBL] [Abstract][Full Text] [Related]
29. Genetic engineering of Escherichia coli for the economical production of sialylated oligosaccharides.
Fierfort N; Samain E
J Biotechnol; 2008 Apr; 134(3-4):261-5. PubMed ID: 18378033
[TBL] [Abstract][Full Text] [Related]
30. Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them.
Viswanathan K; Lawrence S; Hinderlich S; Yarema KJ; Lee YC; Betenbaugh MJ
Biochemistry; 2003 Dec; 42(51):15215-25. PubMed ID: 14690432
[TBL] [Abstract][Full Text] [Related]
31. RNA interference of sialidase improves glycoprotein sialic acid content consistency.
Ngantung FA; Miller PG; Brushett FR; Tang GL; Wang DI
Biotechnol Bioeng; 2006 Sep; 95(1):106-19. PubMed ID: 16673415
[TBL] [Abstract][Full Text] [Related]
32. An investigation of intracellular glycosylation activities in CHO cells: effects of nucleotide sugar precursor feeding.
Wong NS; Wati L; Nissom PM; Feng HT; Lee MM; Yap MG
Biotechnol Bioeng; 2010 Oct; 107(2):321-36. PubMed ID: 20506284
[TBL] [Abstract][Full Text] [Related]
33. Glycoengineering the N-acyl side chain of sialic acid of human erythropoietin affects its resistance to sialidase.
Werner A; Horstkorte R; Glanz D; Biskup K; Blanchard V; Berger M; Bork K
Biol Chem; 2012 Aug; 393(8):777-83. PubMed ID: 22944680
[TBL] [Abstract][Full Text] [Related]
34. Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down.
Möller H; Böhrsch V; Lucka L; Hackenberger CP; Hinderlich S
Mol Biosyst; 2011 Jul; 7(7):2245-51. PubMed ID: 21584309
[TBL] [Abstract][Full Text] [Related]
35. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells.
Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ
Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160
[TBL] [Abstract][Full Text] [Related]
36. Genetic engineering of CHO cells for viral resistance to minute virus of mice.
Mascarenhas JX; Korokhov N; Burger L; Kassim A; Tuter J; Miller D; Borgschulte T; George HJ; Chang A; Pintel DJ; Onions D; Kayser KJ
Biotechnol Bioeng; 2017 Mar; 114(3):576-588. PubMed ID: 27642072
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria.
Kurochkina N; Yardeni T; Huizing M
Glycobiology; 2010 Mar; 20(3):322-37. PubMed ID: 19917666
[TBL] [Abstract][Full Text] [Related]
38. Coexpression of CMP-sialic acid transporter reduces N-glycolylneuraminic acid levels of recombinant glycoproteins in Chinese hamster ovary cells.
Kang DG; Kim CS; Cha HJ
Biotechnol Bioeng; 2019 Nov; 116(11):2815-2822. PubMed ID: 31317538
[TBL] [Abstract][Full Text] [Related]
39. Abnormal glycosylation with hypersialylated O-glycans in patients with Sialuria.
Wopereis S; Abd Hamid UM; Critchley A; Royle L; Dwek RA; Morava E; Leroy JG; Wilcken B; Lagerwerf AJ; Huijben KM; Lefeber DJ; Rudd PM; Wevers RA
Biochim Biophys Acta; 2006 Jun; 1762(6):598-607. PubMed ID: 16769205
[TBL] [Abstract][Full Text] [Related]
40. Production of α2,6-sialylated IgG1 in CHO cells.
Raymond C; Robotham A; Spearman M; Butler M; Kelly J; Durocher Y
MAbs; 2015; 7(3):571-83. PubMed ID: 25875452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
